Saturday November 21, 2009 4:54 PM ET
-
Bank Notes | College Planning | Debt | Elder Care | Employment | Estate Planning | Health Care | Insurance | Marriage & Divorce | Real Estate | Retirement | Taxes
-
Share Price ($):
44.82Price Change:
-0.37 (-0.82%)
Last 10 Quotes
What is this?
AZN
(ASTRAZENECA PLC)
Exchange: NYSE
Industry: Drug Manufacturers/Major
Last Trade 4:01 PM ET 11/20/2009
 |
 |
| Volume: | 1,304,437 |
|---|---|
| Day's Low: | $44.36 |
| 52-wk Low: | $29.96 |
| Previous Close: | $45.19 |
| Dividend: | $0.59 |
| Market Cap: | 64,899,400 |
| Avg Volume: | 1,511,700 |
|---|---|
| Day's High: | $44.82 |
| 52-wk High: | $47.61 |
| Open Price: | $44.38 |
| Yield: | 2.63% |
| P/E (Forward): | 7.00 |
Breaking News
| 10:03 AM | 11/19/2009 | Eli Lilly To Pay $2 Million Cash Severance To Retiring R&D Chief |
| 2:34 AM | 11/19/2009 | AstraZeneca Files Brilinta New Drug Application With FDA |
| 4:54 PM | 11/18/2009 | UPDATE: FDA Panel Votes Against Approving Xolair In Children |
| 12:22 PM | 11/18/2009 | FDA Panel Questions Dosing Levels For Novartis's Xolair |
| 5:08 PM | 11/17/2009 | UPDATE: Crestor Cuts Cardiovascular Problems In Women |
| 4:15 PM | 11/17/2009 | AstraZeneca's Crestor Cuts Cardiovascular Problems In Women |
| 1:25 PM | 11/17/2009 | UPDATE: FDA Warns Doctors On Using Plavix With Heartburn Meds |
Stories & Blogs: Around the Web
| 11/20/2009 | A month into an acquisition, and Merck already sees a benefit. |
| 11/19/2009 | For Lilly's R&D Chief, a $2 Million Exit Handshake |
| 11/18/2009 | It won't be a tough decision for patients to make. |
| 11/18/2009 | ISIS has a hard time at AHA despite good efficacy data. |
| 11/17/2009 | Corporate Watch |
| 11/17/2009 | FDA Plavix Warning |
| 11/17/2009 | Alkermes gains; Cerus, InterMune tumble |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 1.46 | NA | NA |
| EPS, GAAP | 1.46 | 1.19 | 22.69 |
| Consensus Estimate | 1.36 | NA | NA |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | NA | 4.20 | NA |
| EPS, GAAP | 4.99 | 4.19 | 19.09 |
| Consensus Estimate | NA | NA | NA |
| AZN | Industry Average | |
| P/E (TTM) | 8.98 | 16.90 |
| P/E (Forward) | 7.00 | 1.10 |
| PEG Ratio | -2.33 | 0.07 |
| Price/Sales | 2.03 | 3.05 |
| Beta | 0.63 | 0.74 |
Advertisements
Hear our feeds on Jott
Post/View comments about this company
SmartMoney Mobile | Customer Service | Magazine Customer Service | Subscribe to SmartMoney Magazine | Your Profile | Contact Us
About Our Ads | Corrections | Custom Publishing | License Our Content | Media Kit | Press Room | Events | Site Map | Labs |
About Our Ads | Corrections | Custom Publishing | License Our Content | Media Kit | Press Room | Events | Site Map | Labs |
You Are Viewing: SmartMoney.com — Investing, Saving and Personal Finance.
